About
Roger Jeffs retired as President and co-CEO at United Therapeutics in 2016 after a successful 18-year tenure. Dr. Jeffs joined United Therapeutics Corporation during its start-up phase in 1998 as Director of Research, Development, and Medical, and served as the company’s President and Chief Operating Officer from 2001 to 2014 and President & co-CEO from 2015-2016. While at United Therapeutics, Dr. Jeffs helped lead the IPO, oversaw the clinical development and regulatory approval of six products for rare diseases, and managed the commercial effort that led to >20% CAGR and $1.5B annual revenue run rate. United Therapeutics was consistently recognized as one of the fastest growing companies and best places to work during his tenure. Dr. Jeffs received the 2015 Wings of Hope Award from the Solving Kids’ Cancer organization in “recognition of his visionary leadership in advancing cancer research while prioritizing the lives of children”. Dr. Jeffs previously held positions at Amgen, Inc.
Position in the VCSift Database
- • 2 investors hold the Chief Executive Officer (CEO) role in VCSift. Roger Jeffs is one of them.
- • 70 investors are based in Chapel Hill, North Carolina, United States.
Data sourced from 410,343 investor profiles. Updated June 2026.
Investment Focus
- Location
- Chapel Hill, US
Contact Information
Find more investors like Roger
Search Investors